27.11.2015 Incuron announces the receipt of a Notice of Allowance from the U.S. Food and Drug Administration (FDA) for an Investigational New Drug (IND) application (#124239) for CBL0137.
17.11.2015 Incuron Announces Results in Study of Pediatric Neuroblastoma, that have been published in the journal Science Translational Medicine. The reported studies were led by scienti
09.02.2015 Incuron, a joint subsidiary of the Bioprocess Capital Ventures closed-end investment fund and Cleveland BioLabs, Inc., announced updates on clinical progress with lead oncology p
With the support of the innovation center Skolkovo
About us
Incuron, LLC is a Russian Federation based joint venture founded in January 2010 between Russian Closed Mutual Venture Fund "Bioprocess Capital Ventures", and Cleveland BioLabs.
Incuron, LLC is developing an innovative pipeline of drugs to treat oncology for the global markets.
Video
